应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02041 麦科田
休市中 09-18 16:08:30
8.400
+0.385
+4.80%
最高
8.675
最低
8.015
成交量
51.67万
今开
8.015
昨收
8.015
日振幅
8.23%
总市值
45.24亿
流通市值
40.25亿
总股本
5.39亿
成交额
437.36万
换手率
0.11%
流通股本
4.79亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
麦科田(02041)公告推行电子化公司通讯安排 9月18日起实施
公告速递 · 09-18 16:50
麦科田(02041)公告推行电子化公司通讯安排 9月18日起实施
麦科田(02041)发布公司通讯电子化安排 自2026年9月18日起实施
公告速递 · 09-18 16:35
麦科田(02041)发布公司通讯电子化安排 自2026年9月18日起实施
麦科田(02041)拟于2026年9月28日召开董事会审议中期业绩及分红方案
公告速递 · 09-16 18:41
麦科田(02041)拟于2026年9月28日召开董事会审议中期业绩及分红方案
麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧
市场资讯 · 09-13
麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧
麦科田赴港上市:并购拼出的医疗器械版图,暗藏多重隐忧
新浪证券 · 09-11
麦科田赴港上市:并购拼出的医疗器械版图,暗藏多重隐忧
麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧
证券之星 · 09-10
麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧
高瓴重仓,麦科田上市首日跌超40%!多位高管出身迈瑞医疗
红星资本局 · 09-07
高瓴重仓,麦科田上市首日跌超40%!多位高管出身迈瑞医疗
欢迎麦科田医疗(2041.HK)今日上市
香港交易所脈搏/HKExPulse · 09-07
欢迎麦科田医疗(2041.HK)今日上市
异动解读|麦科田盘中下跌34.57%,首日挂牌大幅破发
行情直击 · 09-07
异动解读|麦科田盘中下跌34.57%,首日挂牌大幅破发
【新股IPO】麦科田(02041)首挂破发 午后较招股价低超34%
金吾财讯 · 09-07
【新股IPO】麦科田(02041)首挂破发 午后较招股价低超34%
麦科田港股上市破发:大跌34% 公司市值54亿港元 高瓴是股东
雷递网 · 09-07
麦科田港股上市破发:大跌34% 公司市值54亿港元 高瓴是股东
麦科田正式登陆港交所,市值逾53亿港元,全球一体化医疗器械提供商
独角兽早知道 · 09-07
麦科田正式登陆港交所,市值逾53亿港元,全球一体化医疗器械提供商
麦科田(02041)正式登陆港交所 三大业务协同打造港股医疗设备板块又一标杆
智通财经 · 09-07
麦科田(02041)正式登陆港交所 三大业务协同打造港股医疗设备板块又一标杆
麦科田下周一上市:暗盘跌17% 第一季营收4亿 高瓴是股东
雷递网 · 09-05
麦科田下周一上市:暗盘跌17% 第一季营收4亿 高瓴是股东
麦科田(02041.HK)香港公开发售获436.37倍认购 9月7日上市
中金财经 · 09-04
麦科田(02041.HK)香港公开发售获436.37倍认购 9月7日上市
麦科田(02041.HK):香港公开发售获436.37倍认购 全球发售净筹约4.96亿港元
智通财经 · 09-04
麦科田(02041.HK):香港公开发售获436.37倍认购 全球发售净筹约4.96亿港元
麦科田H股获超436倍认购即将挂牌 42.63%自由流通量满足上市规则
公告速递 · 09-04
麦科田H股获超436倍认购即将挂牌 42.63%自由流通量满足上市规则
麦科田医疗科技——全球发售配发结果公布,发售价每股15.42港元
美股速递 · 09-04
麦科田医疗科技——全球发售配发结果公布,发售价每股15.42港元
老虎暗盘 | 麦科田跌超10%,总市值超74亿港元
老虎资讯综合 · 09-04
老虎暗盘 | 麦科田跌超10%,总市值超74亿港元
麦科田(02041)公布董事会及各专门委员会最新组成
公告速递 · 09-04
麦科田(02041)公布董事会及各专门委员会最新组成
加载更多
公司概况
公司名称:
麦科田
所属市场:
SEHK
上市日期:
--
主营业务:
深圳麦科田生物医疗技术股份有限公司是一家主要提供医疗器械产品的中国公司。该公司通过三个分部开展业务。生命支持产品分部主要提供先进输注设备、麻醉设备及相关耗材的完整集成。微创介入产品分部主要提供专为内窥镜手术设计的医疗器械。体外诊断(IVD)医疗器械分部主要提供无缝集成的尖端医疗检测设备与定制试剂。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02041","market":"HK","secType":"STK","nameCN":"麦科田","latestPrice":8.4,"timestamp":1789718910495,"preClose":8.015,"halted":0,"volume":516700,"delay":0,"changeRate":0.04803493449781657,"floatShares":479221686,"shares":538626686,"eps":0.105,"marketStatus":"休市中","change":0.385,"latestTime":"09-18 16:08:30","open":8.015,"high":8.675,"low":8.015,"amount":4373607,"amplitude":0.082346,"askPrice":8.4,"askSize":100,"bidPrice":8.365,"bidSize":300,"shortable":0,"etf":0,"ttmEps":0.086,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789954200000},"marketStatusCode":7,"adr":0,"listingDate":1788710400000,"exchange":"SEHK","adjPreClose":8.015,"openAndCloseTimeList":[[1789695000000,1789704000000],[1789707600000,1789718400000]],"volumeRatio":1.2060031745882744,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02041","defaultTab":"news","newsList":[{"id":"1103379888","title":"麦科田(02041)公告推行电子化公司通讯安排 9月18日起实施","url":"https://stock-news.laohu8.com/highlight/detail?id=1103379888","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103379888?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:50","pubTimestamp":1789721458,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司(股票代码:02041)于2026年9月18日发布公告称,依据香港联合交易所有限公司证券上市规则,公司已采用以电子方式发布公司通讯的安排。自该日起,所有未来公司通讯将以网站版本形式刊载于公司网站(www.medcaptain.com)及香港联合交易所有限公司披露易网站(www.hkexnews.hk),除非股东提出另外要求,否则将不再发送纸质文件。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164039152","title":"麦科田(02041)发布公司通讯电子化安排 自2026年9月18日起实施","url":"https://stock-news.laohu8.com/highlight/detail?id=1164039152","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164039152?lang=zh_cn&edition=full","pubTime":"2026-09-18 16:35","pubTimestamp":1789720543,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司9月18日公告,根据香港联合交易所有限公司证券上市规则第2.07A条及公司章程细则,自2026年9月18日起,公司将通过电子方式向股东发送后续公司通讯,并仅在股东提出要求时提供纸质版本。公告显示,麦科田未来对“可供采取行动的公司通讯”将采用电子邮件个别发送。如有任何疑问,股东可于工作日9:00-18:00致电卓佳证券登记有限公司,电话 2980 1333,或发送邮件至2041-ecom@vistra.com。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103613100","title":"麦科田(02041)拟于2026年9月28日召开董事会审议中期业绩及分红方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1103613100","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103613100?lang=zh_cn&edition=full","pubTime":"2026-09-16 18:41","pubTimestamp":1789555276,"startTime":"0","endTime":"0","summary":"麦科田9月16日公告称,公司董事会已决定于2026年9月28日(星期一)召开会议,主要议程包括:。公告显示,会议将由董事长兼执行董事刘傑先生主持。截至公告日,董事会成员构成为:。公司提醒投资者关注后续公告,以及时了解董事会会议结果及中期业绩详情。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667811576","title":"麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2667811576","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667811576?lang=zh_cn&edition=full","pubTime":"2026-09-13 15:00","pubTimestamp":1789282800,"startTime":"0","endTime":"0","summary":"截至9月10日收盘,麦科田股价较发行价下跌41.57%。高商誉与渠道集中,是其上市后需要面对的课题。9月7日,麦科田正式在港股挂牌上市交易。然而上市首日,麦科田开盘便破发,未能迎来开门红。2025年,麦科田扭亏为盈,归属净利润5073.8万元。麦科田上市首日股价大幅破发,显示资本市场对其估值与盈利持续性持审慎态度。麦科田称,经销商数目大致与销售计划及区域市场需求一致。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjyj/2026-09-13/doc-inirsqpy4499654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["KCAI","VXUS","BK4588","BK4585","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666938544","title":"麦科田赴港上市:并购拼出的医疗器械版图,暗藏多重隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2666938544","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666938544?lang=zh_cn&edition=full","pubTime":"2026-09-11 15:35","pubTimestamp":1789112100,"startTime":"0","endTime":"0","summary":"近日,麦科田正式开启港股全球发售。盈利脆弱性在 2026 年一季度进一步暴露,上市前夕再度出现 252.7 万元亏损。靠并购快速拼出业务版图的麦科田,即将站上港股资本市场。对于麦科田而言,如何完成并购资产的深度整合、夯实自主研发实力、化解商誉与渠道危机,将决定它能否从并购拼凑的企业,蜕变为具备内生竞争力的医疗器械公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-11/doc-inirmvzx5385233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","KCE","RSPH","BK4585","LNGR","IEIH","02041","BK4588","BK1100","159883","09996","BK1574","HART","MEDX","CALF","GDOC","PTH","LGHT","AGNG","XMMO","MYLD","MDEV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666264569","title":"麦科田港股破发背后:盈利持续性不稳定,高商誉与渠道集中藏隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2666264569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666264569?lang=zh_cn&edition=full","pubTime":"2026-09-10 17:05","pubTimestamp":1789031132,"startTime":"0","endTime":"0","summary":"截至9月10日收盘,麦科田股价较发行价下跌41.57%。高商誉与渠道集中,是其上市后需要面对的课题。9月7日,麦科田正式在港股挂牌上市交易。回溯麦科田的发展历程,业务扩张主要与其持续对外收购的战略密切相关。2025年,麦科田扭亏为盈,归属净利润5073.8万元。麦科田上市首日股价大幅破发,显示资本市场对其估值与盈利持续性持审慎态度。麦科田称,经销商数目大致与销售计划及区域市场需求一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026091000030005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311166","title":"高瓴重仓,麦科田上市首日跌超40%!多位高管出身迈瑞医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311166","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311166?lang=zh_cn&edition=full","pubTime":"2026-09-07 20:24","pubTimestamp":1788783878,"startTime":"0","endTime":"0","summary":"9月7日,深圳麦科田生物医疗技术股份有限公司(简称“麦科田”)正式在港交所主板挂牌上市。然而,这家被高瓴资本重仓押注的企业,并未迎来开门红。上市首日,麦科田开盘即破发,截至收盘报8.8港元/股,较发行价15.43港元大跌42.93%,总市值47.4亿港元。官网显示,麦科田成立于2011年,是一家立足中国的全球化医疗器械提供商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866884520.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866884520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1997245177.USD","LU1720050803.USD","LU1934453819.USD","LU1023057109.AUD","LU0572944931.SGD","LU1820825898.SGD","LU2348773727.SGD","IE00B031HY20.USD","BK0251","LU1997245094.SGD","02041","SGXZ81163826.USD","LU0405327494.USD","LU0327786744.USD","LU0650527681.SGD","IE00B29SXG58.USD","LU1580142542.USD","LU2348774022.SGD","LU1688375341.USD","LU2424517915.HKD","LU0359202008.SGD","LU1979443071.USD","LU0823426308.USD","LU1655091616.SGD","LU2488822045.USD","LU0359201612.USD","SGXZ49509284.SGD","LU1064130708.USD","LU1146622755.USD","LU2153592121.USD","IE0031814852.USD","LU0084288322.USD","300760","LU1794554557.SGD","LU2153591404.USD","LU0823426480.USD","LU2148510915.USD","LU1064131003.USD","IE0008368742.USD","LU1734074674.USD","IE0005HP3H50.USD","IE00B031J352.USD","IPOS","LU0405327148.USD","LU2213484517.USD","LU0594300419.USD","LU1781817850.SGD","LU0605514214.HKD","LU0594300179.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317259","title":"欢迎麦科田医疗(2041.HK)今日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317259","media":"香港交易所脈搏/HKExPulse","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665317259?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:31","pubTimestamp":1788773460,"startTime":"0","endTime":"0","summary":"< 左右滑动查看更多 >今天,我们欢迎深圳麦科田生物医疗技术股份有限公司(2041.HK)登陆香港资本市场。麦科田医疗是一家医疗器械提供商,致力于推动生命支持、微创介入和体外诊断三大领域的创新。我们祝贺麦科田医疗#上市,并期待支持其持续发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA4ODAxMzAyMA==&mid=2664983726&idx=1&sn=ec2ee833679d17d08de09ec3ff6d7c30&chksm=8a4086598023bc64c5c63334bf615fba1beb58704b18c7a4f9cc56f9c3511ce8579b0640aa3a&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102415277","title":"异动解读|麦科田盘中下跌34.57%,首日挂牌大幅破发","url":"https://stock-news.laohu8.com/highlight/detail?id=1102415277","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102415277?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:20","pubTimestamp":1788758439,"startTime":"0","endTime":"0","summary":"9月7日,麦科田正式登陆港交所主板,盘中下跌34.57%,报10.09港元,成交额1.0亿港元。消息面上,麦科田今日首挂即破发,开盘报10.00港元,较招股价15.42港元低约35%。此前暗盘阶段股价已跌超17%,市场对其定价存在较大分歧。深圳麦科田生物医疗技术股份有限公司是一家全球医疗器械提供商,业务涵盖生命支持、微创介入及体外诊断三大板块,产品销往全球逾140个国家及地区。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"麦科田首日挂牌,大幅破发","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399736","title":"【新股IPO】麦科田(02041)首挂破发 午后较招股价低超34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399736","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665399736?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:13","pubTimestamp":1788757995,"startTime":"0","endTime":"0","summary":"金吾财讯 | 麦科田(02041)首日挂牌惟表现欠佳,午后维持于低位,最新报10.06港元,较招股价低34.76%,成交额9881.2万港元。今早首挂开报10.00港元,较招股价低14.77%,每股100股,不计手续费,账面亏损542元。据招股结果,股份最终发售价厘定为每股15.42港元,香港公开发售获大幅超额认购,有效申请57,305份,认购倍数约436.37倍,一手中签率为5.00%。国际发售获适度超额认购,认购倍数约2.35倍。","market":"other","thumbnail":"https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/OTU4MzQ2OThiZDJjMjUyYzEwMTY0ODA5MDg2MDM1OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1990891","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRHC","IPOS","BK4127","REDS","KCE","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399738","title":"麦科田港股上市破发:大跌34% 公司市值54亿港元 高瓴是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399738","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665399738?lang=zh_cn&edition=full","pubTime":"2026-09-07 13:08","pubTimestamp":1788757708,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司(简称:“麦科田”,股票代码:“02041”)今日在港交所上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260907/6392438315044792244879915.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260907/6392438315044792244879915.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35086/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","BK4585","VXUS","KCAI","BK4588","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665298390","title":"麦科田正式登陆港交所,市值逾53亿港元,全球一体化医疗器械提供商","url":"https://stock-news.laohu8.com/highlight/detail?id=2665298390","media":"独角兽早知道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665298390?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:54","pubTimestamp":1788746040,"startTime":"0","endTime":"0","summary":"每股发售价15.42港元,全球发售净筹约4.96亿港元。今日开盘,麦科田报10.00港元/股,市值53.86亿港元。麦科田的产品组合覆盖超过60种生命支持产品、110种微创介入产品及150种体外诊断产品,已累计遍及全球逾140个国家及地区。同期,公司毛利从6.51亿元提升至8.70亿元,毛利率从49.6%提升至53.7%,2026年第一季度进一步升至54.3%。经调整净利润达1.29亿元。本次IPO所得款项净额约4.96亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247613461&idx=1&sn=b37d92af171ca22ddff9d6d524470d7d&chksm=fd705dda300e8c861fbe41603a3187bdcdc51047743ad008e0fa3dab62c499a2d55a1bd58a67&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LGHT","LNGR","MDEV","MEDX","HART","09996","RSPH","02041","PTH","GDOC","AGNG","IEIH","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393974","title":"麦科田(02041)正式登陆港交所 三大业务协同打造港股医疗设备板块又一标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393974","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665393974?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:42","pubTimestamp":1788745371,"startTime":"0","endTime":"0","summary":"凭借生命支持、微创介入、体外诊断三大业务板块的协同布局,公司有望成为港股医疗设备板块的又一标杆。作为一家全球医疗器械提供商,麦科田可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。麦科田此次登陆港股,标志着这家深耕医疗器械赛道十余年的平台型企业正式迈入资本市场。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492582.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159557","HEXmain","02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665903357","title":"麦科田下周一上市:暗盘跌17% 第一季营收4亿 高瓴是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2665903357","media":"雷递网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665903357?lang=zh_cn&edition=full","pubTime":"2026-09-05 08:45","pubTimestamp":1788569128,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司(简称:“麦科田”,股票代码:“02041”)将于2026年9月7日(下周一)在港交所上市。","market":"hk","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260905/6392419470265752751132741.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260905/6392419470265752751132741.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35074/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["IPOS","02041"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2664233969","title":"麦科田(02041.HK)香港公开发售获436.37倍认购 9月7日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2664233969","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664233969?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:17","pubTimestamp":1788520621,"startTime":"0","endTime":"0","summary":"格隆汇9月4日丨麦科田(02041.HK)公告,公司全球发售38,910,600股H股,每股H股15.42港元,所得款项净额4.96亿港元。香港公开发售股份数目占全球发售股份数目10%,获认购436.37倍;国际发售股份数目占全球发售股份90%,获认购倍2.35倍。\r\n\r\n 假设全球发售于2026年9月7日(星期一)上午八时正或之前(香港时间)成为无条件,预期H股将于2026年9月7日(星期一)上午九时正(香港时间)开始在联交所买卖。H股将以每手买卖单位100股H股交易,而股份的股份代号为2041。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260904/32360698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02041","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336489","title":"麦科田(02041.HK):香港公开发售获436.37倍认购 全球发售净筹约4.96亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336489","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664336489?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:52","pubTimestamp":1788519172,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153411678","title":"麦科田H股获超436倍认购即将挂牌 42.63%自由流通量满足上市规则","url":"https://stock-news.laohu8.com/highlight/detail?id=1153411678","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153411678?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:51","pubTimestamp":1788519093,"startTime":"0","endTime":"0","summary":"深圳麦科田生物医疗技术股份有限公司将于2026年9月7日登陆香港联交所主板,股份代码02041。公司本次全球发售H股38,910,600股,发售价每股15.42港元,对应总募资额约6亿元,扣除约1.04亿元发行费用后,预计募资净额约4.96亿元。上市后公司总股本为538,626,686股。香港公开发售部分共接获57,305份有效申请,合计认购约1,699,445,100股,对应超购436.37倍;由于比例未触发回拨机制,最终向香港公众投资者配发3,891,100股H股,占全球发售规模10%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127006129","title":"麦科田医疗科技——全球发售配发结果公布,发售价每股15.42港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127006129","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127006129?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:51","pubTimestamp":1788519069,"startTime":"0","endTime":"0","summary":"麦科田医疗科技——全球发售的配发结果已尘埃落定,每股发售价锁定为15.42港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122886331","title":"老虎暗盘 | 麦科田跌超10%,总市值超74亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122886331","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122886331?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:16","pubTimestamp":1788509766,"startTime":"0","endTime":"0","summary":"9月4日,麦科田暗盘跌超10%,总市值超74亿港元,每股定价15.42港元,每手100股,该公司将于9月7日(下周一)正式在港交所挂牌交易。麦科田是一家全球医疗器械提供商,可满足医疗机构内广泛的临床科室、病房和诊所以及社区卫生中心、检验机构和家庭护理场景的临床需求。在中国,公司的产品已累计覆盖超过6,000家医院,包括约90%的三级甲等医院,覆盖31个省、直辖市及自治区。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110262009","title":"麦科田(02041)公布董事会及各专门委员会最新组成","url":"https://stock-news.laohu8.com/highlight/detail?id=1110262009","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110262009?lang=zh_cn&edition=full","pubTime":"2026-09-04 06:41","pubTimestamp":1788475274,"startTime":"0","endTime":"0","summary":"2026年9月4日,深圳麦科田生物医疗技术股份有限公司发布公告,披露董事会及其下设专门委员会的最新成员名单与职能分工。上述任命信息载明于公司于2026年9月4日刊发的公告中,自公告日期起生效。公告显示,公司通过明确董事会及各专门委员会的职能分配,进一步完善公司治理结构。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02041"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.medcaptain.com","stockEarnings":[{"period":"1week","weight":-0.0433},{"period":"1month","weight":-0.4553},{"period":"ytd","weight":-0.4553}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":-0.0292},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0208},{"period":"1year","weight":-0.0676},{"period":"ytd","weight":-0.0343}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳麦科田生物医疗技术股份有限公司是一家主要提供医疗器械产品的中国公司。该公司通过三个分部开展业务。生命支持产品分部主要提供先进输注设备、麻醉设备及相关耗材的完整集成。微创介入产品分部主要提供专为内窥镜手术设计的医疗器械。体外诊断(IVD)医疗器械分部主要提供无缝集成的尖端医疗检测设备与定制试剂。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"麦科田","nameEN":"MEDCAPTAIN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"麦科田,02041,麦科田股票,麦科田股票老虎,麦科田股票老虎国际,麦科田行情,麦科田股票行情,麦科田股价,麦科田股市,麦科田股票价格,麦科田股票交易,麦科田股票购买,麦科田股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"麦科田(02041)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供麦科田(02041)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}